Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years

Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years

Over the last three decades, the decriminalization and legalization of therapeutic and recreational marijuana consumption have increased. Consequently, the availability of marijuana-based products associated with its therapeutic use has increased. These developments have stimulated research on canna...

Full description

Bibliographic Details
Main Authors:	Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García-García
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Pharmaceuticals
Subjects:	CB1R CB2R sleep disorders psychostimulants depressants
Online Access:	https://www.mdpi.com/1424-8247/18/2/266

Similar Items

CB-SEM IMPLEMENTATION IN R AND PYTHON: A REVIEW AND COMPARATIVE STUDY
by: Souma Kanti Paul, et al.
Published: (2022-01-01)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
by: Reem Smoum, et al.
Published: (2022-10-01)

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
by: Rebecca Ferrisi, et al.
Published: (2022-09-01)

Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
by: Emmanuel S. Onaivi
Published: (2023-03-01)

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
by: Antonella Capozzi, et al.
Published: (2021-12-01)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice
by: A. García-Blanco, et al.
Published: (2023-04-01)

The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease
by: Sheelu Monga, et al.
Published: (2021-11-01)

Maternal sevoflurane exposure induces neurotoxicity in offspring rats via the CB1R/CDK5/p-tau pathway
by: Yuxiao Wan, et al.
Published: (2023-01-01)

Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation
by: Hong Zhu, et al.
Published: (2023-12-01)

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
by: Adriano Mollica, et al.
Published: (2017-01-01)

Cannabidiol interacts with the FXR/Nrf2 pathway and changes the CB1/CB2 receptors ratio in gentamicin-induced kidney injury in rats
by: Vahideh Hokmabady, et al.
Published: (2023-03-01)

Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human ageing hearts
by: Żaneta Piotrowska, et al.
Published: (2018-11-01)

Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
by: Hoda Ranjbar, et al.
Published: (2023-03-01)

Cannabinoid Receptor Type 1 (CB1R) Expression in Limbic Brain Structures After Acute and Chronic Seizures in a Genetic Model of Epilepsy
by: Willian Lazarini-Lopes, et al.
Published: (2020-12-01)

Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
by: Piotr Przybycień, et al.
Published: (2022-08-01)

Endocannabinoids regulate cocaine-associated memory through brain AEA–CB1R signalling activation
by: Hongchun Li, et al.
Published: (2022-11-01)

Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
by: Sally Miller, et al.
Published: (2018-05-01)

The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers
by: Chidera C. Chukwueke, et al.
Published: (2021-02-01)

Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
by: Jessica Parnell, et al.
Published: (2023-07-01)

Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB<sub>1</sub>/CB<sub>2</sub> Receptor Interaction
by: Battistina Asproni, et al.
Published: (2021-04-01)

Dielectrical properties of composites LDPE+CB
by: Škipina Blanka, et al.
Published: (2010-01-01)

Paeoniflorin inhibits APEC-induced inflammation in HD11 cells through the NF-κB signaling pathway by activating CB2R
by: Siyang Shen, et al.
Published: (2025-02-01)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
by: Francesca Gado, et al.
Published: (2022-05-01)

Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity
by: Donovan A. Argueta, et al.
Published: (2019-06-01)

Fmr1 deletion enhances and ultimately desensitizes CB1 signaling in autaptic hippocampal neurons
by: Alex Straiker, et al.
Published: (2013-08-01)

Tumor-derived exosome PPP3CB induce gemcitabine resistance by regulating miR-298/STAT3 in pancreatic cancer
by: Chaojun Wang, et al.
Published: (2024-08-01)

An enquiry to the role of CB1 receptors in neurodegeneration
by: Ignacio Fernández-Moncada, et al.
Published: (2023-08-01)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019-04-01)

A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery
by: Gemma Navarro, et al.
Published: (2023-12-01)

Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
by: Michelle Roche, et al.
Published: (2010-08-01)

Finitely presentable objects in ${\rm(}Cb\text{-}{\bf Sets}{\rm)}_{_{\rm fs}}$
by: Mahdieh Haddadi, et al.
Published: (2024-07-01)

Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain
by: Patricia eRivera, et al.
Published: (2015-09-01)

Novel micellar CB2 receptor agonist with anti-inflammatory action for treating corneal alkali burns in a mouse model
by: Neethi C. Thathapudi, et al.
Published: (2023-12-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)

In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution
by: Amy L. Cherry, et al.
Published: (2024-02-01)

The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma
by: Yi Tang, et al.
Published: (2024-04-01)

Separated finitely supported $Cb$-sets
by: Khadijeh Keshvardoost, et al.
Published: (2020-07-01)

Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CB1 Receptor and EF-Hand Calcium Sensor Interactions
by: Edgar Angelats, et al.
Published: (2018-07-01)

The <it>Caulobacter crescentus</it> phage phiCbK: genomics of a canonical phage
by: Gill Jason J, et al.
Published: (2012-10-01)

Expression and Functions of the CB2 Receptor in Human Leukocytes
by: Mélissa Simard, et al.
Published: (2022-02-01)